Form 4: Niagen Bioscience Insider Buys Shares

Carlos Luis Lopez, SVP and General Counsel of Niagen Bioscience, Inc., acquired 2,314 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• Carlos Luis Lopez, Senior Vice President and General Counsel of Niagen Bioscience, Inc., acquired 2,314 shares of common stock.
• The acquisition occurred on June 30, 2026, at a price of $2.71 per share.
• These shares were purchased under the company's Employee Stock Purchase Plan.
• Following this transaction, Mr. Lopez beneficially owns 4,565 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to the insider purchase, which can indicate confidence, but it is a routine transaction and not a strategic update.

Positives

• Insider purchase of company stock, indicating confidence from a key executive.
• Acquisition made through an Employee Stock Purchase Plan, suggesting a structured and potentially beneficial program for employees.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider purchases, especially through employee plans, can be viewed positively by the market as they often signal management's belief in the company's future prospects. However, this filing is a routine disclosure of a transaction rather than a strategic announcement.

Stakeholder Impact

• Shareholders may view the insider purchase positively, interpreting it as a sign of confidence in the company's value.

Key Dates

Keywords

Niagen Bioscience, NAGE, Form 4, Insider Trading, Employee Stock Purchase Plan, Carlos Luis Lopez, Securities Acquisition